Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway

Clinical trial NCT02598895 · COMPLETED

Trial details

NCT number: NCT02598895
Sponsor: University of Washington
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Castration Levels of Testosterone Castration-Resistant Prostate Carcinoma Metastatic Prostate Carcinoma Prostate Carcinoma Metastatic in the Bone PSA Progression Stage IV Prostate Cancer

Start date: 2016-01-26
Primary completion: 2021-09-14
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.